← Back to All Filings

Pacira BioSciences CFO Sells $143K in Stock for Tax Withholding

Low SignificanceNovember 3, 2025 at 6:03:08 PM EST

Pacira BioSciences, Inc.

$PCRX4CIK: 0001396814

Subscribe to track PCRX

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Pacira BioSciences CFO Sells $143K in Stock for Tax Withholding

Company: Pacira BioSciences, Inc. (PCRX) Form: 4 | Filed: 2025/11/03 Significance: Low

Insider: Cross Shawn Title: Chief Financial Officer | Relationship: Officer

Transaction: • Type: Tax Withholding • Shares: 6,690 • Price: $21.38 • Value: $143,032 • Owned After: 68,310

Key Insight: This is a routine, non-discretionary sale to cover tax obligations from vested stock units, not an open-market sale indicating a change in sentiment.

Market Context: The transaction represents a negligible 0.015% of the company's shares outstanding and has minimal market impact.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Pacira BioSciences, Inc. (PCRX)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The Chief Financial Officer disposed of shares in a non-discretionary transaction to cover tax liabilities associated with vested restricted stock units.
  • Market Impact: Negligible, as the transaction is small and automated, not reflecting insider sentiment.

Company Information

FieldValue
CompanyPacira BioSciences, Inc.
Ticker SymbolPCRX
CIK0001396814
IndustryPharmaceutical Preparations

Insider Information

FieldValue
NameCross Shawn
CIK0001734779
Title/PositionChief Financial Officer
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-10-31
Transaction CodeF - Payment of tax liability by withholding securities
Security TypeCommon Stock
Shares Involved6,690
Price Per Share$21.38
Total Value$143,032.20
Shares Owned After68,310
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$143,032.20
% of Market Cap0.015%
Shares Transacted6,690
% of Shares Outstanding0.015%
Post-Transaction Ownership68,310 shares (0.152% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a company with a market capitalization of $960 million, this $143k transaction is immaterial.
  • Transaction Significance: The transaction is classified as low significance because it represents less than 0.1% of both market capitalization and shares outstanding. Furthermore, its nature as a tax-related withholding diminishes its importance as a market signal.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: This is a routine, non-discretionary 'sell-to-cover' transaction for tax purposes. It does not reflect a voluntary decision by the insider to reduce their holdings and is not expected to influence the stock price.

Volume & Sentiment

  • Expected Volume Impact: None. The transaction is too small to have a noticeable effect on trading volume.
  • Sentiment Indicator: Neutral. The filing is informational and does not carry a bullish or bearish signal.

Additional Context

Special Circumstances

  • The filing's footnote confirms the shares were withheld by the issuer to cover tax obligations upon the vesting of restricted stock units. This is a common and automatic practice.
Topics:#SECFiling#InsiderTrading#PCRX#PaciraBioSciences#Form4#StockAlert#CFO#Investing#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.